Fas and Fas ligand in discordant xenogeneic antibody-dependent cell-mediated cytotoxicity.
Fujiwara
I
I
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Nakajima
H
H
Matsuda
T
T
Mizuta
N
N
Yamagishi
H
H
Oka
T
T
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D015478:Antigens, Heterophile / Q000276:immunology; D017209:Apoptosis; D002999:Clone Cells; D004249:DNA Damage; D053222:Fas Ligand Protein; D006801:Humans; D008214:Lymphocytes / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology*; D051379:Mice; D011994:Recombinant Proteins / Q000096:biosynthesis; D013552:Swine; D014162:Transfection; D014183:Transplantation, Heterologous / Q000276:immunology*; D019014:fas Receptor / Q000235:genetics / Q000502:physiology*
D015478:Antigens, Heterophile; C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D019014:fas Receptor